Clinical evaluation of cefpodoxime proxetil dry syrup in pediatric cutaneous bacterial infection.
Terui
T
T
Department of Dermatology, Tohoku University School of Medicine, Sendai, Japan.
Tagami
H
H
D000293:Adolescent; D001424:Bacterial Infections / Q000188:drug therapy*; D015296:Ceftizoxime / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D002511:Cephalosporins / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D008826:Microbial Sensitivity Tests; D011355:Prodrugs / Q000627:therapeutic use*; D012874:Skin Diseases, Infectious / Q000188:drug therapy* / Q000382:microbiology; D000097627:Cefpodoxime Proxetil
D015296:Ceftizoxime; D002511:Cephalosporins; D011355:Prodrugs; D000097627:Cefpodoxime Proxetil